AK, S. Et Al. 2018. MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics. TAT 2018 – Targeted Anticancer Therapies .

AK, S., TUNCA, B., ERTAŞ, H., UĞRAŞ, N., ÖZTÜRK, E., YILMAZLAR, A. T., ... ÇEÇENER, G.(2018). MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics . TAT 2018 – Targeted Anticancer Therapies

AK, SEÇİL Et Al. "MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics," TAT 2018 – Targeted Anticancer Therapies, 2018

AK, SEÇİL Et Al. "MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics." TAT 2018 – Targeted Anticancer Therapies , 2018

AK, S. Et Al. (2018) . "MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics." TAT 2018 – Targeted Anticancer Therapies .

@conferencepaper{conferencepaper, author={SEÇİL AKSOY Et Al. }, title={MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics}, congress name={TAT 2018 – Targeted Anticancer Therapies}, city={}, country={}, year={2018}}